{"entity":{"id":"lori-pierce","kind":"person","name":"Lori J. Pierce","aka":[],"tldr":"Lori Pierce is a breast radiation oncologist and ASCO past president focused on equity in cancer care.","summary":"Lori Pierce is Professor of Radiation Oncology and Vice Provost at the University of Michigan, within the University of Michigan Rogel Cancer Center, a senior NRG Oncology investigator and past president of the American Society of Clinical Oncology (ASCO) for 2020 to 2021. A breast radiation oncologist, she studies radiotherapy in BRCA carriers and breast cancer outcomes by race, with a focus on health equity. Her papers include a comparison of breast conservation and mastectomy in BRCA1 and BRCA2 mutation carriers with operable breast cancer and ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. Her work spans triple-negative and HR-positive breast cancer and modern radiotherapy.","asOf":"2026-09-08","wikipedia":"https://en.wikipedia.org/wiki/Lori_J._Pierce","links":[{"label":"Michigan Medicine","url":"https://medicine.umich.edu/dept/radiation-oncology"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Pierce%20LJ%5BAuthor%5D"},{"label":"Google Scholar","url":"https://scholar.google.com/scholar?q=Lori%20J.%20Pierce"}],"tags":[],"related":[],"cancers":["tnbc","breast-hr-positive"],"sections":[],"technologies":["imrt-igrt"],"targets":["brca"],"drugs":[],"companies":["nrg-oncology"],"institutions":["michigan-rogel","asco"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["breast-cancer-research-and-treatment"],"dependsOn":[],"notes":[],"role":"Professor of Radiation Oncology and Vice Provost, University of Michigan; NRG Oncology investigator; ASCO Past President (2020-2021)","institutionId":"michigan-rogel","specialisms":["Breast radiotherapy","Health equity","Radiation oncology"],"profiles":[{"label":"Michigan Medicine","url":"https://medicine.umich.edu/dept/radiation-oncology"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Pierce%20LJ%5BAuthor%5D"},{"label":"Google Scholar","url":"https://scholar.google.com/scholar?q=Lori%20J.%20Pierce"}],"papers":[{"title":"Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy","journal":"Breast Cancer Research and Treatment","year":2010,"url":"https://doi.org/10.1007/s10549-010-0894-z","doi":"10.1007/s10549-010-0894-z"},{"title":"Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer","journal":"Journal of Clinical Oncology","year":2006,"url":"https://doi.org/10.1200/JCO.2005.02.7888","doi":"10.1200/JCO.2005.02.7888"}]},"route":"/people/lori-pierce/","neighbours":{"cancer":[{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"},{"id":"tnbc","kind":"cancer","name":"Triple-negative breast cancer (TNBC)","route":"/cancers/tnbc/"}],"technology":[{"id":"imrt-igrt","kind":"technology","name":"IMRT / IGRT (modern external beam)","route":"/technologies/imrt-igrt/"}],"target":[{"id":"brca","kind":"target","name":"BRCA1 / BRCA2 (HRD)","route":"/targets/brca/"}],"company":[{"id":"nrg-oncology","kind":"company","name":"NRG Oncology","route":"/companies/nrg-oncology/"}],"institution":[{"id":"asco","kind":"institution","name":"American Society of Clinical Oncology (ASCO)","route":"/institutions/asco/"},{"id":"michigan-rogel","kind":"institution","name":"University of Michigan Rogel Cancer Center","route":"/institutions/michigan-rogel/"}],"journal":[{"id":"breast-cancer-research-and-treatment","kind":"journal","name":"Breast cancer research and treatment","route":"/journals/breast-cancer-research-and-treatment/"}]}}